Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry

Power to the Patients

Apr 09 2025 | 00:40:32

00:00 / 00:40:32

Show Notes

In this episode of Power to the Patients, Boehringer Ingelheim leaders Christine Sakdalan and Mike Jablonski from discuss how precision psychiatry—using tools like biomarkers and neuroimaging—can personalize treatment for conditions like schizophrenia and depression. They highlight the importance of holistic care, digital therapeutics, and industry collaboration to address unmet needs and improve outcomes in mental health.

Other Episodes

Episode

October 17, 2023 • 00:31:00

Exploring Technology and Patient Engagement in Clinical Trials with Bryan Wylie

Today’s guest is Bryan Wylie, Global and Scientific Director of Clinical Affairs, Operations, and Field. He joins today’s episode to share his thoughts about...

Episode 5

October 31, 2024 • 00:45:40

Building a High Recruiting Site in Alzheimer's

In this episode, Jessica Branning, President of JBran Consulting and former CEO of ClinCloud, shares her work in creating accessible and patient-focused clinical research...

Episode

January 25, 2024 • 00:36:50

Integrating Patient Experience in Clinical Trials with Farah Meghji

How much do you know about the behind-the-scenes process of clinical trials? Our guest today, Farah Meghji, has a unique perspective on the matter...